Bieber, T. .; Beck, L.; Pink, A.; Saeki, H.; Eichenfeld, L.; Werfel, T.; Rosholm, A.; Ropke, M.; Paller, A. . Neutralizing Interleukin-13 Increases Skin Microbial Diversity: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Tralokinumab in Adult Patients With Atopic Dermatitis. J of Skin 2021, 5, s56.